Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 4 2Phase 3 2Phase 1/2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 11Carcinoma, Hepatocellular 4Ovarian Neoplasms 3Neoplasm Metastasis 3Small Cell Lung Carcinoma 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation 1Stomach Diseases 1Progression Free Survival 1PD-L1 Positive Non-small Cell Lung Cancer 1Lung Neoplasms 1HR+/HER2-breast Cancer 1Gastrointestinal Neoplasms 1Fludzoparib" and Anti-angiogenic 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors 1Digestive System Neoplasms 1Differentiated Thyroid Cancer 1Carcinoma, Ovarian Epithelial 1Apatinib 1Advanced Breast Cancer 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × apatinib × Clear all
NCT03042611 2022-07-08

ANGEL

Elevar Therapeutics

Phase 3 Completed
460 enrolled 16 charts
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT03889626 2019-03-26

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

Fudan University

Phase 3 Unknown
242 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Stomach Diseases, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡